PT96852A - Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole - Google Patents

Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole

Info

Publication number
PT96852A
PT96852A PT96852A PT9685291A PT96852A PT 96852 A PT96852 A PT 96852A PT 96852 A PT96852 A PT 96852A PT 9685291 A PT9685291 A PT 9685291A PT 96852 A PT96852 A PT 96852A
Authority
PT
Portugal
Prior art keywords
tetrahydrobenz
aminocarbonyl
propyl
amino
indole
Prior art date
Application number
PT96852A
Other languages
English (en)
Other versions
PT96852B (pt
Inventor
Thomas Joseph Kress
David Lee Varie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT96852A publication Critical patent/PT96852A/pt
Publication of PT96852B publication Critical patent/PT96852B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT96852A 1990-02-26 1991-02-22 Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole PT96852B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48518590A 1990-02-26 1990-02-26

Publications (2)

Publication Number Publication Date
PT96852A true PT96852A (pt) 1991-10-31
PT96852B PT96852B (pt) 1998-07-31

Family

ID=23927224

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96852A PT96852B (pt) 1990-02-26 1991-02-22 Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole

Country Status (28)

Country Link
US (1) US5397799A (pt)
EP (1) EP0444852B1 (pt)
JP (1) JP3157007B2 (pt)
KR (1) KR100208114B1 (pt)
CN (1) CN1027503C (pt)
AT (1) ATE126506T1 (pt)
AU (1) AU629453B2 (pt)
BR (1) BR9100767A (pt)
CA (1) CA2037099C (pt)
CY (1) CY1887A (pt)
DE (1) DE69112099T2 (pt)
DK (1) DK0444852T3 (pt)
ES (1) ES2077796T3 (pt)
FI (1) FI95464C (pt)
GR (1) GR3017940T3 (pt)
HK (1) HK175495A (pt)
HU (1) HU217118B (pt)
IE (1) IE67801B1 (pt)
IL (1) IL97306A (pt)
LV (1) LV10251B (pt)
NO (1) NO174149C (pt)
NZ (1) NZ237181A (pt)
PT (1) PT96852B (pt)
RU (2) RU2034837C1 (pt)
SG (1) SG69975A1 (pt)
TW (1) TW219933B (pt)
YU (1) YU47594B (pt)
ZA (1) ZA911258B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
IL97309A (en) * 1990-02-26 1996-11-14 Lilly Co Eli Intermediates for hexahydrobenz Úcd¾ indoles and process for the preparation of pure enantiomers thereof
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli 6-Substituted-hexahydrobenz (cd) indoles process for their preparation and pharmaceutical compositions containing them
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5643934A (en) * 1991-03-28 1997-07-01 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz [CD]indoles
TW248556B (pt) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
UA53205C2 (en) * 2002-04-03 2006-06-15 Pharmatech Close Joint Stock C Antidepressant formulation and method for its manufacture
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
NZ623002A (en) 2006-06-26 2015-08-28 Akebia Therapeutics Inc Prolyl hydroxylase inhibitors and methods of use
CA2774039A1 (en) 2009-11-06 2011-05-12 Aerpio Therapeutics Inc. Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
CN103717214A (zh) 2011-06-06 2014-04-09 阿克比治疗有限公司 用于稳定低氧诱导因子-2α作为治疗癌症的方法的化合物和组合物
NO2686520T3 (pt) 2011-06-06 2018-03-17
HUE066123T2 (hu) 2013-06-13 2024-07-28 Akebia Therapeutics Inc Készítmények és módszerek anémia kezelésére
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途
CA2974691A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
NZ735973A (en) 2015-04-01 2023-06-30 Akebia Therapeutics Inc Compositions and methods for treating anemia
US11713298B2 (en) 2018-05-09 2023-08-01 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
US12612367B2 (en) 2019-12-10 2026-04-28 Akebia Therapeutics, Inc. Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative
WO2021216530A1 (en) 2020-04-20 2021-10-28 Akebia Therapeutics, Inc. Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles

Also Published As

Publication number Publication date
CN1054589A (zh) 1991-09-18
RU2034837C1 (ru) 1995-05-10
HK175495A (en) 1995-11-24
PT96852B (pt) 1998-07-31
CA2037099C (en) 2001-09-11
EP0444852A2 (en) 1991-09-04
ATE126506T1 (de) 1995-09-15
NO910735L (no) 1991-08-27
EP0444852A3 (en) 1992-02-19
SG69975A1 (en) 2000-01-25
IE910625A1 (en) 1991-08-28
TW219933B (pt) 1994-02-01
JP3157007B2 (ja) 2001-04-16
GR3017940T3 (en) 1996-02-29
ZA911258B (en) 1992-10-28
BR9100767A (pt) 1991-10-29
NO910735D0 (no) 1991-02-25
IL97306A0 (en) 1992-05-25
AU629453B2 (en) 1992-10-01
YU47594B (sh) 1995-10-24
NO174149B (no) 1993-12-13
AU7197191A (en) 1991-08-29
FI95464C (fi) 1996-02-12
FI910895L (fi) 1991-08-27
DE69112099T2 (de) 1996-02-08
LV10251B (en) 1995-04-20
FI95464B (fi) 1995-10-31
KR910021375A (ko) 1991-12-20
HUT56542A (en) 1991-09-30
HU217118B (hu) 1999-11-29
YU32791A (sh) 1994-01-20
LV10251A (lv) 1994-10-20
EP0444852B1 (en) 1995-08-16
ES2077796T3 (es) 1995-12-01
IL97306A (en) 1996-10-16
NZ237181A (en) 1992-06-25
FI910895A0 (fi) 1991-02-25
CN1027503C (zh) 1995-01-25
DK0444852T3 (da) 1995-12-11
CY1887A (en) 1996-04-05
DE69112099D1 (de) 1995-09-21
IE67801B1 (en) 1996-05-01
CA2037099A1 (en) 1991-08-27
KR100208114B1 (ko) 1999-07-15
US5397799A (en) 1995-03-14
RU2083561C1 (ru) 1997-07-10
JPH04217662A (ja) 1992-08-07
NO174149C (no) 1994-03-23

Similar Documents

Publication Publication Date Title
AU629453B2 (en) Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1, 3,4,5-tetrahydrobenz(cd)indole
EP0357946A3 (en) Method for preparing light polarizer
EG19122A (en) Process for preparing of -2- substituted oxindole derivatives
DK29989D0 (da) Bifunktionelt vaekstmodulerende glycoprotein benaevnt amphiregulin
FI883744L (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia
RU92004575A (ru) Кристаллическая соль 4-(ди-н-пропил) амино-6-аминокарбонил-1,3,4,5-тетрагидробенз (cd) индола и ее 4p и 4s-изомеры
GR871752B (en) Method for dying keratin fibres with indol derivatives combined withiodide salts
AU2301988A (en) Process for preparing sulfonylurea salts
FI891700L (fi) Menetelmä beta-laktaamijohdannaisten valmistamiseksi
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
AU7306891A (en) Hydrothermal process for growing optical-quality single crystals
FI895389A7 (fi) Menetelmä 3,5-dimetyyli-4-metoksipyridiinijohdosten valmistamiseksi sekä uusi välituote näitä varten
FI905536A7 (fi) Menetelmä N-glykosidijohdannaisten valmistamiseksi
MX9200793A (es) Tetrahidropirinas y metodo para su preparacion.
FI912163L (fi) Menetelmä substituoitujen indolien valmistamiseksi
AU586757B2 (en) Lid for improved dendritic web growth
AU590603B2 (en) A method of preparing indoles or indole derivatives, coupled via position 4, 5, 6, or 7, the indoles or indole derivatives concerned, as well as the use thereof
DE68900145D1 (de) Brillengestell-traeger fuer eine reproduzier-maschine.
AU1741592A (en) Improved process for preparing benzenesulfonate salts
FI890658A7 (fi) Menetelmä 1,2-disulfoniyhdisteiden valmistamiseksi
KR900005865A (ko) 1,3,5-티아디아진-4-온 유도체의 제조방법
EP0275104A3 (en) Process for preparing 2,3-dihydro-1h-imidazolylalkoxyindene derivatives and pharmaceutically acceptable salts
FI924769A7 (fi) Menetelmä substituoitujen indolien valmistamiseksi
AU2350688A (en) Process for preparing 3,3-disubstituted indolines
IE862252L (en) "a method of preparing indoles or indole derivatives,¹coupled via position 4,5,6, or 7, the indoles or indole¹derivatives concerned, as well as the use thereof"

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910704

FG3A Patent granted, date of granting

Effective date: 19980408

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20071008